QuidelOrtho Appoints Brian J. Blaser as President and Chief Executive Officer

Business Wire05-02

Brian J. Blaser (Photo: Business Wire) Brings More Than Two Decades of Leadership Experience in the In-Vitro Diagnostics Industry SAN DIEGO, May 02, 2024--(BUSINESS WIRE)--QuidelOrtho ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2432708526?lang=en_US&edition=fundamental","thumbnail":"https://s.yimg.com/uu/api/res/1.2/x3OLoQdGoBtHkQjzUk3tng--~B/aD00ODA7dz0zMTI7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/3e9d2dfd31e6a212db8f7be6b6a55340","is_english":true,"pubTime":"2024-05-02 20:00","share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","id":"2432708526","market":"us","top_or_hot":-1,"title":"QuidelOrtho Appoints Brian J. Blaser as President and Chief Executive Officer","media":"Business Wire","content":"<div>\n<p>Brian J. Blaser (Photo: Business Wire)\n \n\n\n\n\n\nBrings More Than Two Decades of Leadership Experience in the In-Vitro Diagnostics Industry\nSAN DIEGO, May 02, 2024--(BUSINESS WIRE)--QuidelOrtho ...</p>\n\n<a href=\"https://finance.yahoo.com/news/quidelortho-appoints-brian-j-blaser-120000057.html\">Source Link</a>\n\n</div>\n","source":"yahoofinance","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>QuidelOrtho Appoints Brian J. Blaser as President and Chief Executive Officer</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nQuidelOrtho Appoints Brian J. Blaser as President and Chief Executive Officer\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-05-02 20:00 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/quidelortho-appoints-brian-j-blaser-120000057.html><strong>Business Wire</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Brian J. Blaser (Photo: Business Wire)\n \n\n\n\n\n\nBrings More Than Two Decades of Leadership Experience in the In-Vitro Diagnostics Industry\nSAN DIEGO, May 02, 2024--(BUSINESS WIRE)--QuidelOrtho ...</p>\n\n<a href=\"https://finance.yahoo.com/news/quidelortho-appoints-brian-j-blaser-120000057.html\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU1989763427.SGD","symbol_name":"CPR Invest - Food For Generations A2 Acc SGD-H","start_time":0,"source_url":"https://finance.yahoo.com/news/quidelortho-appoints-brian-j-blaser-120000057.html","article_id":"2432708526","we_media_id":null,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/x3OLoQdGoBtHkQjzUk3tng--~B/aD00ODA7dz0zMTI7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/3e9d2dfd31e6a212db8f7be6b6a55340"],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2432708526","pubTimestamp":1714651200,"sourceInfo":{"source_id":"yahoofinance","name":"雅虎金融"},"weMediaInfo":null,"summary":"Brings More Than Two Decades of Leadership Experience in the In-Vitro Diagnostics Industry. SAN DIEGO, May 02, 2024----QuidelOrtho Corporation  , a global provider of innovative in-vitro diagnostic technologies designed for point of care settings, clinical labs and transfusion medicine, announced the Company’s Board of Directors  has appointed Brian J. Blaser as President and Chief Executive Officer  effective May 6. In addition to his appointment as President and CEO, Mr. Blaser will join the Board, effective May 15, 2024, when the Board will be expanded from ten to eleven members.\"We are excited to welcome Brian as our new president, CEO and director,\" said Kenneth F. Buechler, Ph.D., Chairman of the Board. \"Brian brings over 25 years of senior leadership experience in the in-vitro diagnostics industry, including seven years of full responsibility for Abbott’s global diagnostics business. His proven track record of executing transformational strategies to streamline operations and dr","collect":0,"end_time":0,"defaultTopTitle":"yahoo.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"LU1989763427.SGD":"CPR Invest - Food For Generations A2 Acc SGD-H","BK4585":"ETF&股票定投概念","BK4533":"AQR资本管理(全球第二大对冲基金)","BK4566":"资本集团","LU1691799644.USD":"Amundi Funds Polen Capital Global Growth A2 (C) USD","LU0122379950.USD":"贝莱德世界健康科学A2","LU0868494617.USD":"UBS (LUX) EQUITY SICAV - US TOTAL YIELD SUSTAINABLE \"P\" (USD) ACC","BK4082":"医疗保健设备","SGXZ23171101.USD":"NIKKO AM SHENTON GLOBAL OPPORTUNITIES (USD) ACC","IE0002141913.USD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"I2\" (USD) ACC","IE00BJJMRZ35.SGD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"I2\" (SGDHDG) ACC","BK4568":"美国抗疫概念","LU2468319806.SGD":"MANULIFE GF HEALTHCARE \"AA\" (SGDHDG) ACC","BK4588":"碎股","IE00BFTCPJ56.SGD":"Janus Henderson Global Life Sciences A Acc SGD","BK4198":"医疗保健用品","LU1989763690.USD":"东方汇理世代食品基金A2 Acc","BK4581":"高盛持仓","LU0170899867.USD":"EASTSPRING INVESTMENTS WORLD VALUE EQUITY  \"A\" (USD) ACC","BK4504":"桥水持仓","LU1023059063.AUD":"BGF WORLD HEALTHSCIENCE \"A2\" (AUDHDG) ACC","IE0009355771.USD":"骏利亨德森环球生命科技A Acc","LU0266013472.USD":"AXA WF - Framlington Longevity Economy A Cap USD","LU1057294990.SGD":"Blackrock World Healthscience A2 SGD-H","IE00BJT1NW94.SGD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"A2\" (SGDHDG) ACC","IE00B2B36J28.USD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"I1\" (USD) INC","LU1914381329.SGD":"Allianz Best Styles Global Equity Cl ET Acc H2-SGD","ABT":"雅培","QDEL":"窥得儿医药","LU0234572021.USD":"高盛美国核心股票组合Acc","SG9999004303.SGD":"Nikko AM Shenton Global Opportunities SGD","SG9999002232.USD":"Allianz Global High Payout USD","BK4592":"伊斯兰概念","SG9999002224.SGD":"Allianz Global High Payout SGD"},"translate_title":"QuidelOrtho任命Brian J.Blaser为总裁兼首席执行官","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"QDEL":0.9,"ABT":0.74},"content_text":"Brian J. Blaser (Photo: Business Wire)\n \n\n\n\n\n\nBrings More Than Two Decades of Leadership Experience in the In-Vitro Diagnostics Industry\nSAN DIEGO, May 02, 2024--(BUSINESS WIRE)--QuidelOrtho Corporation (Nasdaq: QDEL) (the \"Company\" or \"QuidelOrtho\"), a global provider of innovative in-vitro diagnostic technologies designed for point of care settings, clinical labs and transfusion medicine, announced the Company’s Board of Directors (the \"Board\") has appointed Brian J. Blaser as President and Chief Executive Officer (\"CEO\") effective May 6. In addition to his appointment as President and CEO, Mr. Blaser will join the Board, effective May 15, 2024, when the Board will be expanded from ten to eleven members.\n\"We are excited to welcome Brian as our new president, CEO and director,\" said Kenneth F. Buechler, Ph.D., Chairman of the Board. \"Brian brings over 25 years of senior leadership experience in the in-vitro diagnostics industry, including seven years of full responsibility for Abbott’s global diagnostics business. His proven track record of executing transformational strategies to streamline operations and driving revenue growth to dramatically improve profitability makes him an ideal leader to guide QuidelOrtho through its next phase of growth.\"\nMr. Blaser most recently served as Executive Vice President, Diagnostic Products of Abbott Laboratories, where he oversaw the global diagnostics organization, including core laboratory, point of care, rapid diagnostics, and molecular diagnostics businesses. Prior to that role, Mr. Blaser held various strategic, operational, and diagnostic roles at Abbott, as well as previous leadership positions at the Ortho Clinical Diagnostics division of Johnson & Johnson, Eastman Kodak, and General Motors.\n\"I am honored and excited to join QuidelOrtho as president and CEO during this pivotal point in the Company’s journey. The Company’s commitment to customer service and its dedication to improving healthcare outcomes align closely with my own values,\" said Brian J. Blaser, President and CEO, QuidelOrtho. \"I am eager to collaborate with the QuidelOrtho team to drive innovation and continued growth, while delivering value to customers, shareholders and employees.\"\nMr. Blaser holds an MBA with a concentration in Finance from the Rochester Institute of Technology and a Bachelor of Sciences in Mechanical Engineering Technology from the University of Dayton. He is actively involved in various industry and community organizations, including serving as Advisory Council Chair of the University of Dayton School of Engineering and Chairman of the Board of Trustees for Cristo-Rey St. Martin College Prep.\n\"The Board would also like to take this opportunity to thank Michael Iskra, Robert Bujarski and Joseph Busky for their leadership during this transition period. Together, they advanced many critical initiatives while stabilizing a solid foundation for the Company’s continued growth,\" Dr. Buechler said.\nThe Company will report its first quarter 2024 financial results on May 8, 2024.\nAbout QuidelOrtho Corporation\nQuidelOrtho Corporation (Nasdaq: QDEL) is a world leader in in-vitro diagnostics, developing and manufacturing intelligent solutions that transform data into understanding and action for more people in more places every day.\nOffering industry-leading expertise in immunoassay and molecular testing, clinical chemistry, and transfusion medicine, bringing fast, accurate and reliable diagnostics when and where they are needed–from home to hospital, lab to clinic. So that patients, clinicians and health officials can spot trends sooner, respond quicker and chart the course ahead with accuracy and confidence.\nBuilding upon its many years of groundbreaking innovation, QuidelOrtho continues to partner with customers across the healthcare continuum and around the globe to forge a new diagnostic frontier. One where insights and solutions know no bounds, expertise seamlessly connects, and a more informed path is illuminated for each of us.\nQuidelOrtho is advancing diagnostics to power a healthier future.\nFor more information, please visit www.quidelortho.com.\nSource: QuidelOrtho Corporation\nView source version on businesswire.com: https://www.businesswire.com/news/home/20240502548327/en/\nContacts\nInvestor Contact:Juliet CunninghamVice President, Investor RelationsIR@QuidelOrtho.com\nMedia Contact:D. Nikki WheelerSenior Director, Corporate Communicationsmedia@QuidelOrtho.com","kind":null,"is_publish_news":null,"is_publish_highlight":null,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2432708526"}